文献速递流行病学与生物统计临床试验与 GCP

联合模型助力临床试验中患者报告结局的纵向评估:一项模拟研究及限制性与开放性液体治疗用于大型腹部手术(RELIEF)随机对照试验的二次分析

Joint models inform the longitudinal assessment of patient-reported outcomes in clinical trials: a simulation study and secondary analysis of the restrictive Vs. liberal fluid therapy for major abdominal surgery (RELIEF) randomized controlled trial.
PubMed 文献 · J Clin Epidemiol · 2024-10-09

本研究基于RELIEF随机对照试验的二次分析及模拟研究,评估联合模型在处理患者报告结局因死亡而出现信息性缺失时的表现。结果显示联合模型在术后1、3、6、12个月均未发现组间残疾评分差异,模拟中联合模型产生无偏估计,而完整病例分析在所有场景下均高偏倚,最差情况假设偏倚最大。

要点

  • 联合模型可处理患者报告结局中因死亡导致的信息性缺失偏倚。
  • 基于全部可用数据的方法在模拟中与联合模型接近,仅部分场景有轻微偏倚。
  • 完整病例分析和最差情况假设在模拟中产生高偏倚。

核心结论

  • 在采用患者报告结局作为终点的随机试验中,联合模型可解决因死亡相关信息性缺失所导致的偏倚。
  • 基于全部可用数据的方法似乎是联合模型的合理替代方案,在部分模拟场景中仅存在轻微偏倚。

研究设计与样本

  • 研究分两部分:第一部分为对已发表的RELIEF随机对照试验(比较大型腹盆腔手术最初24小时内两种液体治疗方案)的二次分析,患者报告残疾在手术前后多个时间点测量。
  • 第二部分为模拟研究,在九种治疗-结局场景下联合模拟患者报告残疾与生存,类似RELIEF试验。
  • 两部分均将联合模型分析与线性混合效应模型结合传统纵向缺失处理方法(可用数据分析、完整病例分析、末次观测结转、最差情况假设)进行比较。

主要发现

  • 第一部分中,联合模型显示术后1、3、6、12个月患者报告残疾均无组间差异。
  • 最差情况法始终与联合模型估计偏差最大,但在此特定情形下没有一种方法实质性改变研究结论。
  • 第二部分模拟显示,在所有治疗-结局场景中,联合模型对患者报告残疾的估计均无偏。
  • 基于全部可用数据的方法(依赖最大似然估计处理缺失)所得残疾估计接近模拟值,但在部分场景中存在轻微偏倚。
  • 末次观测结转法除治疗对患者报告残疾有非零效应外,与联合模型估计一致;最差情况分析偏倚高,尤其当治疗对生存有较大效应时;完整病例分析在所有场景中偏倚均高。

局限性

  • 第一部分中,在此特定情形下没有一种方法实质性改变研究结论。
  • 基于全部可用数据的方法在部分模拟场景中存在轻微偏倚。
  • 末次观测结转法仅在治疗对患者报告残疾无效应时与联合模型估计一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Evaluate the utility of a joint model when analysing a patient-reported endpoint as part of a randomized controlled trial (RCT) in which censoring occurs when patients die during follow-up. STUDY DESIGN AND SETTING: The present study comprises two parts as follows: first we reanalyzed data from a previously published RCT comparing two fluid regimens in the first 24 hours of major abdomino-pelvic surgery ('Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery [RELIEF]' trial). In this trial, patient-reported disability was measured at multiple timepoints before and after surgery. Next, we conducted a simulation study to jointly emulate patient-reported disability and survival, similar to the RELIEF trial, under nine treatment-outcome scenarios. In both parts, we compared a joint model analysis to a linear mixed-effect model combined with one of the several traditional methods of handling longitudinal missingness as follows: available data analysis, complete case analysis, last observation carried forward, and worst-case assumption. RESULTS: In part one, the joint model revealed no between-group differences in patient-reported disability at 1, 3, 6, and 12 months after surgery. The worst-case approach consistently resulted in the largest deviation from the joint model estimates, although in this particular setting none of the approaches materially changed the study's conclusions. In part two, the simulations revealed that across all treatment-outcome scenarios, the joint model expectedly produced unbiased estimates of patient-reported disability. Similarly, employing an approach based on all available data (ie, relying on the maximum likelihood estimator for handling missingness) yielded disability estimates close to the simulated values, albeit with slight bias across some scenarios. The last observation carried forward approach that mirrored the joint model's estimates except when the treatment had a nonnull effect on patient-reported disability. The worst-case analysis resulted in high bias, which was particularly evident when the treatment had a large effect on survival. The complete case analysis resulted in high bias across all scenarios. CONCLUSION: In randomized trials that employ a patient-reported outcome as one of their endpoints, a joint model can address bias arising from informative missingness related to death. Methods for handling missingness based on all available data appear to be a reasonable alternative to joint models, with only slight bias across some simulated scenarios. PLAIN LANGUAGE SUMMARY: 'Patient-centered research' focuses on outcomes that are prioritized by patients. This approach often involves asking patients to complete questionnaires about their health experiences. However, if a patient does not finish a study, dealing with their missing answers can pose significant challenges. Joint models are a recent statistical method that may help address this issue. In this study, we used joint models in a real-world clinical trial, and in a series of simulated trials, to determine how well they handle missing questionnaire data from patients. We found that joint models offer significant benefits over most traditional methods used to analyze clinical trials.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Daza JF, Mitani AA, Alibhai SMH, et al. Joint models inform the longitudinal assessment of patient-reported outcomes in clinical trials: a simulation study and secondary analysis of the restrictive Vs. liberal fluid therapy for major abdominal surgery (RELIEF) randomized controlled trial. J Clin Epidemiol. 2024. PMID: 39389273. doi:10.1016/j.jclinepi.2024.111553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。